[
  {
    "ts": "2025-11-11T14:45:00+00:00",
    "headline": "Alpha-1 Antitrypsin Deficiency Disease Market Research Report 2025, Competitive Analysis of Shire, GSK, CSL Behring, AstraZeneca, Grifols, Teva Pharma, Boehringer Ingelheim, Kamada, Pfizer, Baxter",
    "summary": "The Alpha-1 Antitrypsin Deficiency Disease market offers opportunities in developing targeted therapies due to an increasing diagnosed patient population, advances in genetic testing, and innovative treatments like enzyme replacement and gene therapies. Growing awareness and technological advancements further drive this niche market. Alpha-1 Antitrypsin Deficiency Disease Market Alpha-1 Antitrypsin Deficiency Disease Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The \"Alpha-1 Antitrypsin Defic",
    "url": "https://finance.yahoo.com/news/alpha-1-antitrypsin-deficiency-disease-144500372.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f07ad033-766a-3dc0-ba0f-8c65759da254",
      "content": {
        "id": "f07ad033-766a-3dc0-ba0f-8c65759da254",
        "contentType": "STORY",
        "title": "Alpha-1 Antitrypsin Deficiency Disease Market Research Report 2025, Competitive Analysis of Shire, GSK, CSL Behring, AstraZeneca, Grifols, Teva Pharma, Boehringer Ingelheim, Kamada, Pfizer, Baxter",
        "description": "",
        "summary": "The Alpha-1 Antitrypsin Deficiency Disease market offers opportunities in developing targeted therapies due to an increasing diagnosed patient population, advances in genetic testing, and innovative treatments like enzyme replacement and gene therapies. Growing awareness and technological advancements further drive this niche market. Alpha-1 Antitrypsin Deficiency Disease Market Alpha-1 Antitrypsin Deficiency Disease Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The \"Alpha-1 Antitrypsin Defic",
        "pubDate": "2025-11-11T14:45:00Z",
        "displayTime": "2025-11-11T14:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/b758584bda253b07bac3e3b6702aa59c",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Alpha-1 Antitrypsin Deficiency Disease Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cYQMQXo33Umij_exyn_EGg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b758584bda253b07bac3e3b6702aa59c.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.H5bj2NyuUkxggUOvWujVw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b758584bda253b07bac3e3b6702aa59c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/alpha-1-antitrypsin-deficiency-disease-144500372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/alpha-1-antitrypsin-deficiency-disease-144500372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "GRF.MC"
            },
            {
              "symbol": "KMDA.TA"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T21:30:00+00:00",
    "headline": "Baxter Declares Quarterly Dividend",
    "summary": "DEERFIELD, Ill., November 11, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on Jan. 2, 2026, to stockholders of record as of Nov. 28, 2025. The indicated annual dividend rate equates to $0.04 per share of common stock.",
    "url": "https://finance.yahoo.com/news/baxter-declares-quarterly-dividend-213000959.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a3f5ab83-3222-3f40-8f7b-867a683bbba8",
      "content": {
        "id": "a3f5ab83-3222-3f40-8f7b-867a683bbba8",
        "contentType": "STORY",
        "title": "Baxter Declares Quarterly Dividend",
        "description": "",
        "summary": "DEERFIELD, Ill., November 11, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per share of common stock. The dividend is payable on Jan. 2, 2026, to stockholders of record as of Nov. 28, 2025. The indicated annual dividend rate equates to $0.04 per share of common stock.",
        "pubDate": "2025-11-11T21:30:00Z",
        "displayTime": "2025-11-11T21:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/baxter-declares-quarterly-dividend-213000959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/baxter-declares-quarterly-dividend-213000959.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]